Loading clinical trials...
Loading clinical trials...
Extreme Phenotypes to Identify the Patients With Type 2 Diabetes Who Are Susceptible or Resistant to Complications and to Reveal the Mechanisms
Conditions
Locations
3
Italy
Policlinico Consorziale di Bari
Bari, BA, Italy
Azienda Rilievo Nazionale Alta Specialità (ARNAS) Garibaldi
Catania, CT, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, PI, Italy
Start Date
May 1, 2024
Primary Completion Date
November 30, 2025
Completion Date
July 31, 2026
Last Updated
November 26, 2025
NCT07467460
NCT07391995
NCT05776420
NCT05268237
NCT05610865
NCT05999773
Lead Sponsor
Azienda Ospedaliero, Universitaria Pisana
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions